These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

561 related articles for article (PubMed ID: 27339602)

  • 1. New prospects for targeting telomerase beyond the telomere.
    Arndt GM; MacKenzie KL
    Nat Rev Cancer; 2016 Aug; 16(8):508-24. PubMed ID: 27339602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overcoming the immortality of tumour cells by telomere and telomerase based cancer therapeutics--current status and future prospects.
    Kelland LR
    Eur J Cancer; 2005 May; 41(7):971-9. PubMed ID: 15862745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the telosome: therapeutic implications.
    Folini M; Gandellini P; Zaffaroni N
    Biochim Biophys Acta; 2009 Apr; 1792(4):309-16. PubMed ID: 19419699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telomere inhibition and telomere disruption as processes for drug targeting.
    Rezler EM; Bearss DJ; Hurley LH
    Annu Rev Pharmacol Toxicol; 2003; 43():359-79. PubMed ID: 12540745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticancer therapy targeting telomeres and telomerase : current status.
    Parkinson EK; Minty F
    BioDrugs; 2007; 21(6):375-85. PubMed ID: 18020621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of telomerase inhibitors: existing strategies and emerging innovations.
    Kageler L; Aquilanti E
    Biochem Soc Trans; 2024 Aug; 52(4):1957-1968. PubMed ID: 39194999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Inhibition of telomeres and telomerase. Seeking for new anticancer drugs].
    Raymond E; Faivre S; Dieras V; Von Hoff D
    Bull Cancer; 1997 Dec; 84(12):1123-33. PubMed ID: 9587365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telomere and telomerase as targets for anti-cancer and regeneration therapies.
    Hsu YH; Lin JJ
    Acta Pharmacol Sin; 2005 May; 26(5):513-8. PubMed ID: 15842766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telomere biology of pediatric cancer.
    Tabori U; Dome JS
    Cancer Invest; 2007; 25(3):197-208. PubMed ID: 17530490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Telomerase inhibitor].
    Kyo S; Inoue M
    Gan To Kagaku Ryoho; 2001 May; 28(5):614-21. PubMed ID: 11383209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Telomeres, telomerase and cancer].
    Soria JC; Rixe O
    Bull Cancer; 1997 Oct; 84(10):963-70. PubMed ID: 9435798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Agents that target telomerase and telomeres.
    Raymond E; Sun D; Chen SF; Windle B; Von Hoff DD
    Curr Opin Biotechnol; 1996 Dec; 7(6):583-91. PubMed ID: 8939642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological intervention strategies for affecting telomerase activity: future prospects to treat cancer and degenerative disease.
    Tárkányi I; Aradi J
    Biochimie; 2008 Jan; 90(1):156-72. PubMed ID: 17945408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting human telomerase in cancer therapy.
    Huard S; Autexier C
    Curr Med Chem Anticancer Agents; 2002 Sep; 2(5):577-87. PubMed ID: 12678725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in the molecular design of potential anticancer agents via targeting of human telomeric DNA.
    Maji B; Bhattacharya S
    Chem Commun (Camb); 2014 Jun; 50(49):6422-38. PubMed ID: 24695755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of telomerase inhibitors for the treatment of cancer.
    Cairns D; Anderson RJ; Perry PJ; Jenkins TC
    Curr Pharm Des; 2002; 8(27):2491-504. PubMed ID: 12369943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telomerase and its potential for therapeutic intervention.
    Phatak P; Burger AM
    Br J Pharmacol; 2007 Dec; 152(7):1003-11. PubMed ID: 17603541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telomeres and telomerase as targets for anticancer drug development.
    Olaussen KA; Dubrana K; Domont J; Spano JP; Sabatier L; Soria JC
    Crit Rev Oncol Hematol; 2006 Mar; 57(3):191-214. PubMed ID: 16469501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telomeres, telomerase and cancer: an endless search to target the ends.
    Satyanarayana A; Manns MP; Rudolph KL
    Cell Cycle; 2004 Sep; 3(9):1138-50. PubMed ID: 15467446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Telomere maintenance as a target for anticancer drug discovery.
    Neidle S; Parkinson G
    Nat Rev Drug Discov; 2002 May; 1(5):383-93. PubMed ID: 12120414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.